Vivanza Biosciences Ltd.
BSE: 530057
₹1.77
₹-0.04
(-2.21%)
As on 22-May-2026IST
Market cap
₹7 Cr
Revenue (TTM)
₹116 Cr
P/E Ratio
18
P/B Ratio
1.6
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹0 Cr
-
ROE
-15.7 %
-
ROCE
-2.8 %
-
Industry P/E
52.22
-
EV/EBITDA
20.4
-
Debt to Equity
0.2
-
Book Value
₹1.1
-
EPS
₹0.1
-
Face value
1
-
Shares outstanding
40,000,000
10 Years Aggregate
CFO
₹-0.06 Cr
EBITDA
₹1.30 Cr
Net Profit
₹0.07 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Vivanza Bioscience
| -19.5 | -14.1 | -15.7 | -37.7 | -50.5 | -23.7 | -12.4 |
|
BSE Healthcare
| 8.8 | 8.8 | 9.7 | 11.0 | 27.5 | 14.1 | 12.0 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
|---|---|---|---|---|---|---|
|
Vivanza Bioscience
| -39.7 | -69.4 | -30.5 | -12.9 | 55.9 | 759.1 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Vivanza Bioscience
|
1.8 | 7.1 | 115.9 | 0.4 | 0.6 | 8.9 | 18 | 1.6 |
| 2,951.2 | 24,140.1 | 1,339.4 | 356.4 | 33.2 | 23.2 | 67.8 | 14.6 | |
| 3,107.5 | 38,804.4 | 5,452.9 | 1,056.0 | 22.4 | 23.9 | 36.7 | 8.6 | |
| 1,713.6 | 32,463.4 | 9,203.5 | 941.3 | 15.4 | 19.6 | 35.1 | 6.6 | |
| 2,192.6 | 35,263.5 | 4,147.8 | 709.5 | 22.3 | 18.3 | 49.7 | 8.5 | |
| 26.2 | 32.7 | 12.5 | -3.0 | -90.2 | -2.7 | -- | 0.3 | |
| 16,693.0 | 21,341.3 | 2,023.0 | 364.0 | 23.9 | 20.8 | 58.6 | 11.4 | |
| 4,670.8 | 21,395.8 | 2,519.7 | 722.4 | 33.6 | 18.8 | 29.6 | 5.1 | |
| 175.6 | 23,328.3 | 8,869.1 | -383.1 | 1.0 | -4.2 | -- | 2.9 | |
| 1,575.4 | 25,598.2 | 3,373.0 | 199.0 | 12.6 | 5.9 | 120.2 | 5.2 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Vivanza Bioscience
Wholesale of pharmaceutical and medical goods
-
Incorporated
1982
-
Chairman
--
-
Managing Director
JA Mehta
-
Headquarters
Ahmedabad, Gujarat
-
Website
Looking for more details about Vivanza Biosciences Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
FAQs for Vivanza Bioscience
What is the current share price of Vivanza Biosciences Ltd Today?
The share price of Vivanza Biosciences Ltd is ₹1.77 (BSE) as of 22-May-2026 IST. Vivanza Biosciences Ltd has given a return of -50.47% in the last 3 years.
What is the current PB & PE ratio of Vivanza Biosciences Ltd?
The P/E ratio of Vivanza Biosciences Ltd is 17.97 times as on 22-May-2026, a 66 discount to its peers’ median range of 52.22 times.
The P/B ratio of Vivanza Biosciences Ltd is 1.62 times as on 22-May-2026, a 459 premium to its peers’ median range of 0.29 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
2.01
|
|
2024
|
49.63
|
5.86
|
|
2023
|
125.69
|
18.38
|
|
2022
|
22.66
|
21.61
|
|
2021
|
69.34
|
16.53
|
What is the 52 Week High and Low of Vivanza Biosciences Ltd?
The 52-week high and low of Vivanza Biosciences Ltd are Rs 2.83 and Rs 1.75 as of 23-May-2026.
What is the market cap of Vivanza Biosciences Ltd?
Vivanza Biosciences Ltd has a market capitalisation of ₹ 7 Cr as on 22-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Vivanza Biosciences Ltd?
Before investing in Vivanza Biosciences Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.